India's Laurus Labs extends gains to hit record high on quarterly profit jump

Laurus Labs

27/07/2026 09:51

** Pharmaceutical products maker Laurus Labs LAUL.NS jumps as much as 7.9% to a record high of 1,727.70 rupees apiece
** LAUL extends gains following 2.1% rise on Friday, after it more than doubled its June quarter profit Y/Y
** Goldman Sachs raises its financial year 2027-2029 earnings per share estimates by 20%-29% to factor in the profit beat, citing updated pipeline progression 
** Maintains "sell" on higher valuations, but raises price target to 1,250 rupees from 1,100 rupees
** Jefferies terms Q1 performance a "strong beat", driven by growth in custom synthesis division
** Higher contribution from CDMO and operating leverage benefits led to operating profit margin hitting a near-all-time high of 31.5%, says Jefferies
** Average rating of 13 analysts tracking LAUL is "hold"; median PT of 1,250 rupees - data compiled by LSEG
** LAUL rises 55.3% in 2026 so far, outperforming 14% rise in pharma index .NIPHARM, exchange data shows

(Reporting by Bharath Rajeswaran in Bengaluru)
((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))